Publications

    1. Role of Enhancers in development and diseases. Maurya S. Published in Epigenomes (https://doi.org/10.3390/epigenomes5040021)
    2. Loss of KMT2C reprograms the epigenomic landscape in human pluripotent cells resulting in NODAL overexpression and a failure of hemogenic endothelium specification. Maurya S. et al. Published in Epigenetics.(PMID: 34304711)
    3. KDM6A knockout in human iPSCs alters the genome-wide histone methylation profile at active and poised enhancers, activating expression of ectoderm gene expression pathways. Maurya S. et al. BioRxiv (doi: https://doi.org/10.1101/2021.03.09.434633)
    4. Polymorphisms in drug-metabolizing enzymes and risk to head and neck cancer: Evidence for gene–gene and gene–environment interaction. Shailendra S. Maurya, Gautam Anand, Ankur Dhawan, Anwar J. Khan, Swatantra K. Jain, Mohan C. Pant, Devendra Parmar.” Environ Mol Mutagen. 2014 Mar; 55(2): 134-44.
    5. Gene-environment interactions in determining differences in genetic susceptibility to cancer of head and neck subsites”.Shailendra S. Maurya, TridivKatiyar, Dhawan A, Jain SK, Pant MC, Parmar D. Environ Mol Mutagen. 2015,56(3): 313-21. (Considered for best paper award from EMGS society)
    6. Association of cytochrome P450 1B1 haplotypes with head and neck cancer risk”. 2017. TridivKatiyar, Shailendra S Maurya, Feza Hasan, Arvind P Singh, Anwar J Khan, Rahat Hadi, Sudhir Singh, Madan LB Bhatt, Devendra Parmar. Environmental and molecular mutagenesis 58 .6, 443-450.
    7. Interaction of cytochrome P450s with environmental risk factors increases their expression and risk to head and neck cancer. Tridiv Katiyar, Vinay Yadav, Shailendra S. Maurya, Feza Hasan, Arvind P. Singh, Sanjay Yadav, Sudhir Singh, Rahat Hadi, Madan Lal B. Bhatt, Devendra Parmar. https://doi.org/10.1002/em.22495. Environ Mol Mutagen. 2022.
    8. Similarities in mRNA expression of peripheral blood drug metabolizing enzymes and cancer marker genes with biopsy samples of head and neck cancer patients”. Feza Hasan, TridivKatiyar, Shailendra S Maurya, Vinay Yadav, Sanjay Yadav, Rahul Pandey, Divya Mehrotra, Rahat Hadi, Sudhir Singh, Madan L Bhatt, Devendra Parmar. 2019. Biomarkers, Sep; 24.6.574-583.
    9. Sunishtha S. Yadav, Shilpi Seth, Anwar J. Khan, Shailendra S. Maurya, Ankur Dhawan ,Sidharth Pant, Mohan C. Pant, Devendra Parmar. “Association of polymorphismin cytochrome P450 2C9 with susceptibility to head and neck cancer and treatment outcome”. Applied & Translational Genomics Volume 3, Issue 1, 1 March 2014, Pages 8–13.
    10. Rahul Pandey, Divya Mehrotra, Abbas Ali Mahdi, Rajiv Sarin, PradnyaKowtal, Shailendra S. Maurya, Devendra Parmar. “Association between mitochondrial c tract alteration and tobacco exposure in oral precancer cases”. National Journal of Maxillofacial Surgery | Vol 4 | Issue 2 | Jul-Dec 2013 | 219-224.
    11. Abhishek Mishra, DivyaSanghi, Amar Chandra Sharma, Saloni Raj, Shailendra Shanker Maurya, SachinAvasthi, Ajai Singh, Devendra Parmar and Rajeshwar Nath Srivastava. “Association of Polymprphisms in growth and differentiation factor 5 Gene with Osteoarthritis Knee”. American Journal of Biochemistry and Biotechnology, 2013, 9 (1), 1-7.
    12. Multiplicative interaction of polymorphic drug metabolizing enzymes with environmental risk factors increases the susceptibility to head & neck cancer. Tridiv Katiyar, PhD; Vinay Kumar Yadav, Msc; Dr Shailendra Shanker Maurya, Dr Arvind P. Singh,Dr Sudhir Singh,Dr Rahat Hadi, Dr M L B Bhatt,  Under review in Genomics.

     

    Presentations

    Poster presentations

    1. Shailendra Maurya, Magiee Ferris, Will Yang, Tamai Manori, Wing Hing Wong. Loss of KMT2C reset the epigenetic landscape in hiPSCs. Gordon Research Conferences 2019, Epigenetics July 21,2019-July 26, 2019. Holderness School in Holderness NH United States.

     

    1. Shailendra Maurya, Minori Tamai, Will Yang, Maggie Ferris, wing Hing Wong Todd Druley. Loss of Histone Methyltransferase (KMT2C) Reprograms the Epigenetic Enhancer Priming of Pluripotent cells. Epigenetics Symposium 15 years of Lysine Demethylases From Discovery to the Clinic, December 16, 2019. Fox Chase Cancer Center Philadelphia, PA 19103.

     

    1. Dhawan A., Ruwali M., Maurya S.S., Khan A.J., Pant M.C., Singh S., Gupta D., Shukla P., Bisht S.S., Verma J., Parmar D. Association of genetic polymorphisms in drug metabolizing enzymes and susceptibility to head and neck squamous cell carcinoma and treatment response. Presented at National Oncology Update-2010 (5th Meeting of Armed Forces Oncology Group), Organized by Oncology Centre, Command Hospital (Central Command), Lucknow, India, from July 24-25, 2010. The presentation was awarded the first prize.

     

    1. Shailendra Shanker Maurya, MunindraRuwali, Mohan Chand Pant, Devendra Parmar. Functionally important polymorphisms in carcinogen metabolizing enzyme and susceptibility to Head and Neck Cancer (HNSCC). Presented at XXXVI Annual Conference of Environmental Mutagen Society of India (EMSI) held at VIT Vellore from 2 Feb 2011 to 5 Feb 2011.

     

    1. Shailendra Shanker Maurya, Swantantra K Jain, Mohan C. Pant and Devendra Parmar. Role of gene-gene and gene- environment interaction in determining risk to Head and Neck cancer.  Presented at XXXII Annual Conference Society of toxicology (STOX), India to be held at CSIR-Indian Institute of Toxicology Research, Lucknow, India, from December 5 – 7, 2012.

     

    1. Shailendra Shanker Maurya, S. K. Jain, Mohan Chand Pant, Devendra Parmar. “Combined effect of genetic Polymorphisms in CYP1A1, CYP1B1 with GSTM1 as Risk Factors for the Development of Head and Neck cancer" for 44th Annual conference of Indian Pharmacological society held at Manipal from 19th -21st December.